Vanda Pharmaceuticals (VNDA) Change in Acquisitions & Divestments (2016 - 2025)
Vanda Pharmaceuticals' Change in Acquisitions & Divestments history spans 16 years, with the latest figure at $47.0 million for Q4 2025.
- On a quarterly basis, Change in Acquisitions & Divestments fell 51.35% to $47.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $208.2 million, a 40.85% decrease, with the full-year FY2025 number at $208.2 million, down 40.85% from a year prior.
- Change in Acquisitions & Divestments hit $47.0 million in Q4 2025 for Vanda Pharmaceuticals, up from $35.6 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for VNDA hit a ceiling of $350.4 million in Q1 2023 and a floor of $35.6 million in Q3 2025.
- Historically, Change in Acquisitions & Divestments has averaged $95.3 million across 5 years, with a median of $85.1 million in 2022.
- Biggest five-year swings in Change in Acquisitions & Divestments: surged 289.0% in 2023 and later plummeted 82.73% in 2024.
- Tracing VNDA's Change in Acquisitions & Divestments over 5 years: stood at $79.4 million in 2021, then rose by 0.74% to $80.0 million in 2022, then surged by 40.14% to $112.1 million in 2023, then decreased by 13.83% to $96.6 million in 2024, then tumbled by 51.35% to $47.0 million in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for VNDA at $47.0 million in Q4 2025, $35.6 million in Q3 2025, and $38.0 million in Q2 2025.